News
Data shows economic benefit to Amplimune use
NovaVive Inc., an animal health immunobiology company, today announced that research data related to its regulator-approved immunotherapy for calf scours (Amplimune®) was presented at the 2019 American Association of Bovine Practitioners (AABP) Annual Conference in [Read More …]
